Sustained remission for mycosis fungoides following duvelisib and mogamulizumab
Kiera Murphy, Christopher Bazewicz · 2026
Read Sustained remission for mycosis fungoides following duvelisib and mogamulizumab by Kiera Murphy, Christopher Bazewicz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13380011.txt.
Description
Kiera Murphy and Christopher Bazewicz describe a 2026 case of lasting remission in a skin lymphoma after two drugs were used together. The disease, mycosis fungoides, is the most common lymphoma of the skin and often needs combined treatment when advanced. Their patient was a 67-year-old man whose patches, plaques, and tumours covered about half his skin.
One tumour on his cheek had changed into a more aggressive form. Earlier treatments, including light therapy, radiation, and creams, had not held the disease back, and a newer drug was failing. The two drugs, each known to affect the immune system, were then combined. The report details the course that followed and the side effects to watch for with this pairing.
Catalog record
| CREATOR | Kiera Murphy, Christopher Bazewicz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7962 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |